The relation between apoptosis of acinar cells and nitric oxide during acute rejection of pancreas transplantation in rats

Transplant Immunology

Volumn 11, Issue 1, 2003, Pages 15-21

  Xiaoguang, Ni ^b   Zhong, Liu ^a   Hailong, Chen ^a   Ping, Zhao ^b   Xiaofeng, Bai ^a   Fenglin, Guan ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Aminoguanidine; Apoptosis; Graft rejection; Nitric oxide; Pancreas transplantation

Indexed keywords

AMINOGUANIDINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRANSFERASE;

ACINAR CELL; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; GRAFT REJECTION; HISTOPATHOLOGY; IMMUNE RESPONSE; ISOGRAFT; MALE; NICK END LABELING; NONHUMAN; PANCREAS DISEASE; PANCREAS TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; GRAFT REJECTION; IN SITU NICK-END LABELING; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PANCREAS; PANCREAS TRANSPLANTATION; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR;

EID: 0038029739     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(02)00148-X     Document Type: Article

References (27)

1. Zimmermann KC, Bonzon C, Green DR. The machinery of programmed cell death. Pharmacol Ther 2001;92(1):57-70.
2. Tilney NL, Kupiec-Weglinski JW, Heidecke CD, Lear PA, Strom TB. Mechanism of rejection and prolongation of vascularized organ allografts. Immunol Rev 1984;77:185-216.
3. Kabelitz D. Apoptosis, graft rejection, and transplantation tolerance. Transplantation 1998;65(7):869-875.
4. Hibbs JB Jr, Taintor RR, Vavrin Z. Macrophage cytotoxicity: Role of L-arginine deiminase and amino nitrogen oxidation to nitrite. Science 1987;235(4787):473-476.
5. Devlin J, Palmer RM, Gonde CE, et al. Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation 1994;58(5):592-595.
6. Langrehr JM, Murase N, Markus PM, et al. Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J Clin Invest 1992;90(2):679-683.
7. Szabolcs MJ, Ravalli S, Minanov O, Sciacca RR, Michler RE, Cannon PJ. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation 1998;65(6):804-812.
8. Boonstra JG, Wever PC, Laterveer JC, et al. Apoptosis of aciner cells in pancreas allograft rejection. Transplantation 1997;64(8):1211-1213.
9. Tanaka S, Kamiiki W, Ito T, et al. Generation of nitric oxide as a rejection marker in rat pancreas transplantation. Transplantation 1995;60(7):713-717.
10. Corbett JA, Tilton RG, Chang K, et al. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 1992;41(4):552-556.
11. Lee S, Tung K.S, Koopmans H, Chandler JG, Orloff MJ. Pancreatioduodenal transplantation in the rat. Transplantation 1972;13(4):421-425.
12. Nakhleh RE, Sutherland DE, Tzardis P, Schechner R, Gruessner RW. Correlation of rejection of the duodenum with rejection of the pancreas in a pig model of pancreaticoduodenal transplantation. Transplantation 1993;56(6):1353-1356.
13. Matsuno T, Saski H, Nakagawa K, et al. Fas antigen expression and apoptosis in kidney allografts. Transplant Proc 1997;29(1-2):177-178.
14. Dubernard JM, Rahbar M, Martin X, Laftavi MR, Lefrancois N. Pancreatic transplantation. Transplant Proc 1995;27(5):2641-2643.
15. Hall BM. Cells mediating allograft rejection. Transplantation 1991;51(6):1141-1151.
16. Wu CJ, Lovett M, Wong-Lee J, et al. Cytokine gene expression in rejecting cardiac allografts. Transplantation 1992;54(2):326-332.
17. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988;141(7):2407-2412.
18. Palmer RM. The L-arginine: Nitric oxide pathway. Curr Opin Nephrol Hypertens 1993;2(1):122-128.
19. Lowenstein CJ, Snyder SH. Nitric oxide, a novel biologic messenger. Cell 1992;70(5):705-707.
20. Cattell V, Smith J, Jansen A, Riveros-Moreno V, Moncada S. Localization of inducible nitric oxide synthase in acute renal allograft rejection in the rat. Transplantation 1994;58(12):1399-1402.
21. Yang X, Chowdhury N, Cai B, et al. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 1994;94(2):714-721.
22. Szabolcs M, Michler RE, Yang X, et al. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation 1996;94(7):1665-1673.
23. Stuehr DJ, Nathan CF. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989;169(5):1543-1555.
24. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87(4):1620-1624.
25. -/- recipients correlates with reduced apoptosis. Circulation 1999;99(6):836-842.
26. Friedman EA. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes Care 1999;22(Suppl. 2):B65-B71.
27. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992;15(12):1835-1843.